News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Jennifer R. Frytak, PhD

Articles by Jennifer R. Frytak, PhD

Medical Costs After Initiation of Drug Treatment for Overactive Bladder: Effects of Selection Bias on Cost Estimates

ByNicole M. Nitz, PhD,Zhanna Jumadilova, MD, MBA,Theodore Darkow, PharmD,Jennifer R. Frytak, PhD,Tamara Bavendam, MD

July 15th 2005

Treatment Compliance and Dosage Administration Among Rheumatoid Arthritis Patients Receiving Infliximab, Etanercept, or Methotrexate

ByCarolyn R. Harley, PhD,Jennifer R. Frytak, PhD,Neeta Tandon, MA

October 1st 2003

Latest Updated Articles

Trending on AJMC

Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings

Rusfertide Keeps Working Where Hydroxyurea Fades: Andrew Kuykendall, MD

Lymphoma Outcomes Hinge on Oncology, Not Viral Load In People With HIV

Consensus Helps Dermatologists Spot CTCL Mimicking Atopic Dermatitis on Dupilumab

New Mechanism of DME Treatment Highlights Clinical Trial Updates